SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is generating massive market buzz following its high-profile public debut, with investors deeply divided over whether the company's multi-trillion dollar valuation reflects revolutionary long-term potential or unsustainable hype. The community is actively debating the stock's future, as traders closely monitor high volatility and look ahead to upcoming options trading, index inclusion, and the potential impact of insider lock-up expirations.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending following a Bloomberg report that the streaming company is exploring a potential sale, with discussions reportedly underway with at least one major U.S. media entity. The community is actively debating the credibility of these buyout rumors and the company's long-term strategic value, leading to significant volatility as traders analyze the potential for a premium acquisition against the backdrop of an increasingly competitive streaming landscape.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as the community closely monitors the progress of its $110 billion acquisition of Warner Bros. Discovery following the Department of Justice's approval. Shareholders are actively debating the potential for long-term synergy value, the impact of ongoing regulatory reviews in Europe, and the strategic implications of management's integration plans while remaining focused on upcoming deal closing milestones.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is experiencing heightened interest as investors weigh record-high Nasdaq levels against volatile geopolitical developments, including U.S.-Iran tensions. The community is actively debating the sustainability of the AI-driven tech rally and the risks associated with holding triple-leveraged instruments in an environment characterized by inflation concerns and potential policy shifts.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean Ltd. is currently trending as investors weigh strong backlog growth and improved operational efficiency against geopolitical uncertainty in the Strait of Hormuz. The community is actively debating whether the stock's recent performance is tethered more to daily fluctuations in oil prices or the long-term potential of its merger with Valaris and ongoing debt reduction efforts.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential for future adoption versus extreme price volatility and frustration over a lack of major updates from the Flexa team. While community sentiment is heavily polarized between long-term holders citing the utility of the Anvil and Flexa ecosystem and critics pointing to the token's persistent downward trend, active discussions remain focused on legislative catalysts like the CLARITY Act and alleged institutional activity in staking pools.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is surging as investors react to a significant regulatory delay for its primary competitor, Aquestive Therapeutics, effectively extending SPRY's lead as the only approved needle-free epinephrine treatment. The community is actively discussing a potential short squeeze, fueled by high short interest and institutional accumulation, as the company scales its global market presence.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as the stock surges following a major announcement that it is breaking ground on an expanded multi-billion dollar semiconductor packaging campus in Arizona. The community is actively discussing this expansion as a key play on domestic semiconductor onshoring and the growing necessity of advanced packaging to support the AI supply chain.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors await the first full commercial revenue report for YARTEMLEA, with the community actively debating whether the company can meet high expectations following its recent FDA approval and partnership deals. Discussion is dominated by speculation over whether recent price volatility is driven by institutional shakeouts ahead of upcoming EMA regulatory decisions or by ongoing short interest as the company shifts into a commercial-stage growth phase.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL is capturing significant community attention as investors position it alongside established meme coins, with many touting its long-standing cultural relevance and potential for exponential growth. Enthusiasm is centered on the project's ownership of original IP rights and active grassroots campaigns aimed at driving massive adoption within the broader meme ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Humana Closes the Kindred Chapter With $900 Million Gentiva Exit

HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.

Humana To Sell Gentiva Minority Stake In $900 Mln Deal

(RTTNews) - Humana Inc. (HUM) announced that it has entered into a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, a provider of end-of-life services including hospice and palliative care. The agreement v...

Humana Announces Agreement to Divest Minority Interest in Gentiva

Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nations leading provider of end-of-life services, including hospice and palliative care. The agreement values...

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would...

UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too?

UNH has surged 20% this year, but with valuation rising and investigations ongoing, is the easy money already gone?

UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose

UNH raises its dividend again, extending a long streak of annual increases despite a smaller hike.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina 

UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.

5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation  

Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?

UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM PR Newswire NEW ORLEANS, May 29, 2026 NEW...

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

HUMHumana Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HUM News